78206-0147 Ontruzant - CanMED: NDC

Product NDC:

78206-0147

Brand Name:

Ontruzant

Generic Name:

trastuzumab

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/1

Packages:

Code: 78206-0147-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)

Effective Date: June 1, 2021

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox